Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis

Michelle T. Long; Emelia Benjamin

doi:10.1161/circimaging.118.007553

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2025

Prevalent Cardiovascular Disease and Atrial Fibrillation in Relation to Cerebral Small Vessel Disease Burden

Oluchi Ekenze, Adlin Pinheiro, Alexa S. Beiser, Vasileios‐Arsenios Lioutas, Hugo J. Aparicio, Emelia Benjamin, Ramachandran S. Vasan, Charles DeCarli, Sudha Seshadri, Serkalem Demissie, José R. Romero

Article2020

332 HEPATIC FIBROSIS AS MEASURED BY VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY IN A COMMUNITY-BASED COHORT IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR RISK FACTORS: THE FRAMINGHAM HEART STUDY

Michelle T. Long, Xiaoyu zhang, Hanfei Xu, Yongmei Liu, Emelia Benjamin

Article2016

Transfer function-derived central pressure and cardiovascular disease events

Gary F. Mitchell, Shih‐Jen Hwang, Martin G. Larson, Naomi M. Hamburg, Emelia Benjamin, Ramachandran S. Vasan, Daniel Levy, Joseph A. Vita

Article2016

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

Hans-Theo Schon, Matthias Bartneck, Erawan Borkham‐Kamphorst, Jacob Nattermann, Twan Lammers, Frank Tacke, Ralf Weiskirchen

Article2007

Association of γ’ Fibrinogen with Risk Factors and Prevalent Cardiovascular Disease in the Framingham Heart Study.

Rehana Sultana Lovely, Joseph F. Massaro, Ralph B. D’Agostino, Emelia Benjamin, Steven C. Kazmierczak, Christopher J. O’Donnell, David H. Farrell